Hepatobiliary cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben-Josef, P. Mark Bloomston, Jean F. Botha, Bryan M. Clary, Anne Covey, Steven A. Curley, Michael I. D'Angelica, Rene Davila, William D. Ensminger, John F. Gibbs, Daniel Laheru, Mokenge P. Malafa, Jorge Marrero, Steven G. Meranze, Sean J. Mulvihill, James O. Park, James A. Posey, Jasgit SachdevRiad Salem, Elin R. Sigurdson, Constantinos Sofocleous, Jean Nicholas Vauthey, Alan P. Venook, Laura Williams Goff, Yun Yen, Andrew X. Zhu

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Abstract

Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.

Original languageEnglish
Pages (from-to)350-351+366-390
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume7
Issue number4
DOIs
StatePublished - Apr 2009

Keywords

  • Biologic therapy
  • Chemoembolization
  • Chemotherapy
  • Cholangiocarcinomas
  • Cirrhosis
  • Gallbladder cancer
  • Hepatitis
  • Hepatocellular carcinoma
  • NCCN Clinical practice Guidelines
  • Surgical resection
  • Transplantation
  • Tumor ablation

Cite this